UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000039671 |
|---|---|
| Receipt number | R000045187 |
| Scientific Title | A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions |
| Date of disclosure of the study information | 2021/12/31 |
| Last modified on | 2022/07/07 17:19:44 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions
Acronym
A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions
Scientific Title
A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions
Scientific Title:Acronym
A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions
Region
| Japan |
Condition
Condition
Healthy adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the effect on cognitive function of ONO-SR/AST-SOYPC daily intake, for 12 weeks
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Tests for cognitive functions
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
NO
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Intake of test food daily intake, for 12 weeks
Interventions/Control_2
Intake of placebo daily intake, for 12 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 60 | years-old | <= |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
(1) Healthy males and females from 60 to 85 years of age
(2) Subjects with self-awareness of forgetfulness or Those who are pointed out that there is forgetfulness
Key exclusion criteria
(1) Subjects who constantly use health food richly containing involvement ingredient
(2) Subjects who regularly take drugs or health foods which may affect this study more than once a week
(3) Subjects whose visual acuity is too low to perform test
(4) Subjects whose hearing acuity is too low to perform test
(5) Subjects having a disease of mental disorder, dementia, cranial nerve disease, or cerebrovascular disease.
(6) Subjects with current menopausal disorders
(7) Subjects taking drugs that may affect the results of the study
(8) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required
(9) Subjects having a drug dependence, alcohol dependence requiring treatment or a history of serious alcohol dependence
(10) Subjects suspected of having dementia based on cognitive function tests and physician interviews.
(11) Subjects who may experience irregularities in their lives more than once during the study period due to night shifts, etc.
(12) Subjects who are current smokers or have started smoking cessation within 12 months before the pre-treatment test.
(13) Subjects who have performed the cognitive tests within 12 months prior to the pre-treatment test.
(14) Subjects who donated or transfused 200 mL or 400 mL of whole blood within 3 months before the pre-treatment test.
(15) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study.
(16) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on the pre-treatment test.
(17) Subjects at risk of developing allergy in relation to the study.
(18) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire
(19) Subjects judged as unsuitable for the study by the investigator for other reasons.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Yasunari |
| Middle name | |
| Last name | Noda |
Organization
ONO PHARMACEUTICAL CO., LTD.
Division name
Business Design Department
Zip code
541-8564
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka
TEL
06-6263-2924
ya.noda@ono.co.jp
Public contact
Name of contact person
| 1st name | Takashi |
| Middle name | |
| Last name | Nakagawa |
Organization
TTC Co., Ltd.
Division name
Clinical Research Planning Department
Zip code
150-0021
Address
Seibu Shinkin Bank Ebisu Bldg., 1-20-2, Ebisunishi, Shibuya-ku, Tokyo
TEL
03-5459-5329
Homepage URL
t.nakagawa@ttc-tokyo.co.jp
Sponsor or person
Institute
TTC Co., Ltd
Institute
Department
Personal name
Funding Source
Organization
Ono Pharmaceutical co.,ltd
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Station Clinic Research Ethics Committee
Address
3-12-8, Takaban, Meguroku, Tokyo
Tel
03-6452-2712
t.saito@ttc-smo.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 12 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
100
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2020 | Year | 02 | Month | 13 | Day |
Date of IRB
| 2020 | Year | 02 | Month | 13 | Day |
Anticipated trial start date
| 2020 | Year | 03 | Month | 02 | Day |
Last follow-up date
| 2020 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2020 | Year | 03 | Month | 03 | Day |
Last modified on
| 2022 | Year | 07 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045187
